Hilly Paige Shares Key Takeaways from 2025 ESC/EAS Cholesterol Guideline
Hilly Paige, Chief Innovation Officer at the Family Heart Foundation, has shared a post on LinkedIn:
“Great overview by Family Heart Foundation of the new cholesterol guidelines from European Society of Cardiology and European Atherosclerosis Society.
Figure 2 from the 2025 update is superb. Combinations of proven therapies can lower LDL-C by up to 86%! With so many safe and effective therapies available in the toolbox, it is unacceptable that currently <30% of high-risk individuals are achieving their LDL-C goals!
Also, great to see two important LDL-C lowering therapies included in the 2025 update – bempedoic acid from Esperion and evinacumab from Regeneron!
Finally, using supplements to lower your LDL-C? Don’t waste your money.”

Check here for more information.
Stay informed with Hemostasis Today.
- 
                    Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
 - 
                    Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
 - 
                    Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
 - 
                    Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
 - 
                    Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
 
- 
                    Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
 - 
                    Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
 - 
                    Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
 - 
                    Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
 - 
                    Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
 
- 
                    Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
 - 
                    Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
 - 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
 - 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
 - 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
 
- 
                    Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
 - 
                    Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
 - 
                    Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
 - 
                    Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
 - 
                    Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!
 
